bioRN C-Level Circle: The Talent Advantage – hosted by PROGEN

bioRN C-Level Circle: The Talent Advantage – hosted by PROGEN

The bioRN C-Level Circle is the networking format exclusively for CEOs, CFOs, CSOs, CMOs and Executives from global enterprises and a space for trusting exchange, peer coaching and strategic discussions. Each event is
dedicated to a current hot topic with direct relevance for decision-makers in the life science industry.  Beyond the impulses, the evening is designed to foster meaningful peer-to-peer exchange among Life Science executives in a trusted and confidential setting. Together, we want to discuss common challenges, identify opportunities for collaboration and strengthen the leadership community of our region.

The next bioRN C-Level Circle is hosted by PROGEN.

Topic:

The Talent Advantage –How people become a company’s greatest competitive advantage.

Preliminary Agenda:

5:45: Registration and Welcome

6pm – 7:30: Impuls Talks

  • Beyond Salary: What attracts talent today –  Katja Betts, CEO at PROGEN
  • Retention: Why excellent employees stay with the company? Laura Heggen, Head of Sales bei voiio
  • Growth starts with people: Why companies can only grow as fast as their ability to attract and develop the right people. Carolin Windlin, Head of HR, AGC Biologics

7:30 – 9 pm – Networking with delicious drinks and food *

*Cost: approx. €30 per person. A selection of food and drinks will be offered at cost price. 

We are looking forward to meet you there!

Please note that every registration will be checked and confirmed promptly.

register now

Our latest News

discover more
AlphaFold Database adds viral protein complexes to support pandemic preparedness

AlphaFold Database adds viral protein complexes to support pandemic preparedness

by Sera Guli The latest release includes protein structure predictions for thousands of viruses, which could improve the response to future outbreaks AI-predicted protein complex structures for over 2,800 viruses are now openly available in the AlphaFold Database. To better understand and protect against emerging pathogens, the dataset prioritises proteomes from viral families known to […]

European Commission grants €57 million to critical open data resources

European Commission grants €57 million to critical open data resources

Horizon Europe funding will support GENCODE, UniProt, and Europe PMC The European Commission has announced €57 million in funding to support GENCODE, UniProt, and Europe PMC. These life sciences data resources are delivered and managed by EMBL’s European Bioinformatics Institute (EMBL-EBI) alongside international partners. The financial support will be given in the shape of three […]

Harnessing Synthetic Cellular Systems as Immune Cell Boosters

Harnessing Synthetic Cellular Systems as Immune Cell Boosters

How can cell-based immunotherapies for cancer and autoimmune diseases become more widely available in the long term? The SYNTHIA project is addressing this challenge: The Max Planck Institute for Medical Research and the Fraunhofer Institute for Cell Therapy and Immunology IZI are collaborating on new research approaches to advance the development of cell-based immunotherapies. The […]

GET IN TOUCH

Stay Updated with bioRN’s Newsletter

Sign up for our newsletter to discover more!
* required

BioRN (BioRN Network e.V. and BioRN Cluster Management GmbH) will use the information you provide on this form to be in touch with you and to provide updates and marketing. Please let us know all the ways you would like to hear from us:

You can update your subscription preferences or unsubscribe at any time. Just follow the unsubscribe or update link in the footer of automated emails you receive from us, or by contacting us at info@biorn.org. We will treat your information with respect. For more information about our privacy practices please visit our website: www.biorn.org. By clicking below, you agree that we may process your information in accordance with these terms.

We use Mailchimp as our marketing platform. By clicking below to subscribe, you acknowledge that your information will be transferred to Mailchimp for processing. Learn more about Mailchimp's privacy practices.

Intuit Mailchimp